SCHEMBL25533636

SCHEMBL25533636

CC1(C)c2cc(-c3ccccc3)ccc2-c2ccc(-c3ccc(-c4cc(-c5ccc(-c6ccccc6)cc5)nc(-c5ccccc5)n4)c4ccccc34)cc21

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 10/20 0.45
KMT2A Q03164 10/20 0.45
HPGD P15428 8/20 0.45
MAPT P10636 8/20 0.45
ALDH1A1 P00352 7/20 0.45
NTSR1 P30989 1/20 0.45
KDM4E B2RXH2 5/20 0.41
NPSR1 Q6W5P4 1/20 0.41
RXFP1 Q9HBX9 1/20 0.41
CYP2C19 P33261 1/20 0.41
LMNA P02545 2/20 0.40
GLA P06280 1/20 0.40
ADORA2A P29274 1/20 0.40
ADORA1 P30542 1/20 0.40
ACACA Q13085 1/20 0.38
MAOB P27338 3/20 0.37
MAOA P21397 2/20 0.37
TDP1 Q9NUW8 2/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
DHODH Q02127 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25533626 1.00 MEN1 (0.45) MEN1KMT2AHPGDMAPTALDH1A1
SCHEMBL25533641 0.97 MEN1 (0.45) MEN1KMT2AHPGDMAPTALDH1A1
SCHEMBL25533653 0.97 MEN1 (0.45) MEN1KMT2AHPGDMAPTALDH1A1
SCHEMBL25533634 0.95 MEN1 (0.42) MEN1KMT2AHPGDMAPTALDH1A1
SCHEMBL25533485 0.95 MEN1 (0.43) MEN1KMT2AHPGDMAPTALDH1A1
SCHEMBL25533492 0.95 MEN1 (0.43) MEN1KMT2AHPGDMAPTALDH1A1
SCHEMBL25533550 0.95 MEN1 (0.43) MEN1KMT2AHPGDMAPTALDH1A1
SCHEMBL25533677 0.94 MEN1 (0.40) MEN1KMT2AHPGDMAPTALDH1A1
SCHEMBL25533558 0.94 MEN1 (0.42) MEN1KMT2AHPGDMAPTALDH1A1
SCHEMBL25533666 0.94 MEN1 (0.42) MEN1KMT2AHPGDMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-01 US disclosed
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE PIEZO1, LEF1, L1CAM MEN1 267/4885KMT2A 1094/4885HPGD 3854/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.